Skip to main content
. 2020;22(3):110–123.

TABLE 1.

Prostate Cancer Risk Stratification

Risk Level Very Lowa Lowa Intermediateb Highb Very Highb
Clinical stage T1c T1–T2a T2b–T2c T3a T3b–T4
Gleason score (GS) ≤6 ≤6 7 8–10 8–10
Prostate-specific antigen (ng/mL) <10 <10 10–20 >20 >20
Additional findings <3 cores positive, ≤50% cancer in each core, PSA density <0.15 ng/mL/g Primary Gleason pattern 5, >4 cores GS 8–10
a

Must meet all criteria.

b

Meets any criteria.

Adapted from National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Prostate Cancer Version 1.20208; Prostate Cancer Patient Guide.9